Table 1.
Demographic characteristics of African American–Diabetes Heart Study participants
Variable | Female (n = 270) | Male (n = 152) | All (n = 422) | |
---|---|---|---|---|
Age (years) | Mean (s.d.) | 56.2 (9.5) | 57 (9.9) | 56.5 (9.6) |
Median | 56 | 57 | 56 | |
Diabetes duration (years) | Mean (s.d.) | 10.3 (7.4) | 10.3 (8.1) | 10.3 (7.6) |
Median | 8 | 7.5 | 8 | |
BMI (kg/m2) | Mean (s.d.) | 36.8 (8.2) | 32 (7) | 35 (8.1) |
Median | 35.8 | 31 | 33.7 | |
ACEI or ARB use | N (%) | 136 (50.37) | 75 (49.34) | 211 (50) |
Systolic BP (mm Hg) | Mean (s.d.) | 137.5 (21.5) | 135.7 (17.9) | 136.8 (20.3) |
Median | 135 | 135 | 135 | |
Diastolic BP (mm Hg) | Mean (s.d.) | 76 (12.4) | 77.5 (11.1) | 76.6 (11.9) |
Median | 75.5 | 77.5 | 76 | |
Lipid meds | N (%) | 132 (49.07) | 69 (46) | 201 (47.97) |
Insulin | N (%) | 117 (43.49) | 61 (40.13) | 178 (42.28) |
Smoking | Never | 127 (51.84) | 36 (25.53) | 163 (42.23) |
Former | 70 (28.57) | 59 (41.84) | 129 (33.42) | |
Current | 48 (19.59) | 46 (32.62) | 94 (24.35) |
Excludes 26 subjects with coronary artery bypass surgery and 9 with carotid endarterectomy.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; BP, blood pressure.